$67.77
-2.29-3.27%
Last update: Jun 10, 5:34 PM
$68.04
-2.02-2.88%
Twist Bioscience Corp Stock Guidance
TWSTNASDAQ
Twist Bioscience (TWST) last issued guidance on May 4, 2026 for fiscal year 2026. The company guided revenue in the range of $442.00M - $447.00M for the period.
Compared to prior guidance, Twist Bioscience raised its revenue forecast from a prior range of $435.00M - $440.00M.
Twist Bioscience has issued 37 guidance updates between August 5, 2022 and May 4, 2026. During this period, the company raised its outlook 16 times and lowered it 13 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 4, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$442.00M - $447.00M
Twist Bioscience Guidance History
Review all historical guidance issued by Twist Bioscience, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Twist Bioscience (TWST)?
The most recent guidance for Twist Bioscience (TWST) was reported on May 4, 2026 for the fiscal year 2026. Twist Bioscience forecasted revenue between $442.00M and $447.00M for the period.
What revenue range did Twist Bioscience (TWST) guide for?
Twist Bioscience (TWST) guided revenue in the range of $442.00M to $447.00M for the fiscal year 2026.
Did Twist Bioscience (TWST) raise or lower guidance?
Twist Bioscience (TWST) raised its revenue guidance from a prior range of $435.00M - $440.00M to $442.00M - $447.00M for the fiscal year 2026.
When did Twist Bioscience (TWST) last issue guidance?
Twist Bioscience (TWST) last issued guidance on May 4, 2026 for the fiscal year 2026.
